L094-3026 Screening compound: 1-(2-fluorophenyl)-4-{1-[2-(4-methylphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-yl]piperidine-4-carbonyl}piperazine

L094-3026 Screening compound: 1-(2-fluorophenyl)-4-{1-[2-(4-methylphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-yl]piperidine-4-carbonyl}piperazine
L094-3026 Screening compound: 1-(2-fluorophenyl)-4-{1-[2-(4-methylphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-yl]piperidine-4-carbonyl}piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound L094-3026
1-(2-fluorophenyl)-4-{1-[2-(4-methylphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-yl]piperidine-4-carbonyl}piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L094-3026

Molecular Formula

C28H30FN7O (C28 H30 FN7 O)

Compound Name

1-(2-fluorophenyl)-4-{1-[2-(4-methylphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-yl]piperidine-4-carbonyl}piperazine

IUPAC name

1-(2-fluorophenyl)-4-{1-[2-(4-methylphenyl)-2H-pyrazolo[34-d]pyrimidin-4-yl]piperidine-4-carbonyl}piperazine

SMILES

Cc(cc1)ccc1-n(cc12)nc2ncnc1N(CC1)CCC1C(N(CC1)CCN1c(cccc1)c1F)=O

InChI

InChI=1S/C28H30FN7O/c1-20-6-8-22(9-7-20)36-18-23-26(32-36)30-19-31-27(23)34-12-10-21(11-13-34)28(37)35-16-14-33(15-17-35)25-5-3-2-4-24(25)29/h2-9,18-19,21H,10-17H2,1H3

InChI Key

IIKYCQPBIBRCMN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27231982

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

499.59

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.610

Distribution Coefficient, logD

4.603

Water Solubility, LogSw

-4.24

Polar Surface Area

58.216

Acid Dissociation Constant (pKa)

19.81

Base Dissociation Constant (pKb)

5.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.70

L094-3026 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with L094-3026 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L094-3026?
Check Price and Availability of L094-3026, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L094-3026 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L094-3026
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L094-3026
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L094-3026 available by request